The intravenous therapy and vein access devices market size has grown strongly in recent years. It will grow from $33.15 billion in 2025 to $35.79 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to limited availability of advanced iv therapy devices, reliance on conventional catheters and needles, growing hospital and clinic infrastructure, increasing demand for blood-based products and medication administration, awareness of infection control protocols.
The intravenous therapy and vein access devices market size is expected to see strong growth in the next few years. It will grow to $48.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of implantable ports and advanced infusion pumps, rising adoption of needleless connectors and iv administration sets, expansion of ambulatory surgical centers, integration of smart monitoring and digital solutions, increasing investment in patient safety and regulatory compliance. Major trends in the forecast period include rising demand for peripheral and central venous access devices, increasing adoption of safety-engineered needles and catheters, growth in infusion pump technologies and patient-controlled analgesia systems, expansion of nutrition and medication administration applications, enhanced focus on sterility, accuracy, and regulatory compliance.
The increasing number of surgical procedures is increasingly supporting the expansion of the intravenous therapy and vein access devices market going forward. The rising demand for elective surgeries, including cosmetic procedures, plastic surgery, rhinoplasty, and other non-essential surgical interventions, has contributed significantly to the overall increase in surgical volumes. Intravenous therapy and vein access devices play a critical role in surgical settings by enabling the administration of anesthesia, medications, fluids, and nutrients, maintaining patient stability, and allowing rapid medical intervention when required. For example, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, the total number of surgical and non-surgical procedures increased by 3.4% in 2023 to reach 34.9 million. This increase was supported by a 5.5% rise in surgical procedures, with plastic surgeons performing over 15.8 million surgical procedures and 19.1 million non-surgical procedures, representing a 40% overall increase over the past four years. As a result, the growing volume of surgical procedures is contributing to the expansion of the intravenous therapy and vein access devices market.
Leading companies operating in the intravenous therapy and vein access devices market are developing short peripheral intravenous catheters to improve patient comfort, reduce insertion-related complications, and enhance the efficiency of fluid and medication delivery. Short peripheral intravenous catheters provide rapid and reliable venous access for administering fluids, medications, and nutrients while minimizing discomfort and lowering infection risk. For example, in October 2023, B. Braun, a Germany-based medical device company, launched the Introcan Safety 2 IV Catheter. This short peripheral catheter features passive needlestick prevention and a Multi-Access blood control septum, providing automatic needlestick protection and minimizing exposure to bloodborne pathogens each time the hub is accessed.
In June 2023, Merit Medical Systems, Inc., a US-based healthcare technology company, acquired the dialysis catheter product portfolio and the BioSentry Biopsy Tract Sealant System from AngioDynamics, Inc. for an undisclosed amount. Through this acquisition, Merit Medical aimed to strategically broaden its product portfolio in key markets, particularly dialysis and biopsy. AngioDynamics, Inc. is a US-based medical device company that supplies products for intravenous therapy, vein access, and other medical applications.
Major companies operating in the intravenous therapy and vein access devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., 3M Company, Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Terumo Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., Teleflex Incorporated, Smiths Medical, Nipro Corporation, Argon Medical Devices Inc., Angiplast Private Limited, Poly Medicure Limited, Iradimed Corporation.
North America was the largest region in the intravenous therapy and vein access devices market in 2025. The regions covered in the intravenous therapy and vein access devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravenous therapy and vein access devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intravenous therapy and vein access devices market by increasing the cost of imported catheters, needles, infusion pumps, and implantable ports. Segments such as advanced infusion pumps and implantable ports are most impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to elevated production costs and supply chain adjustments. On the positive side, tariffs have promoted local manufacturing, encouraged innovation in device design, and boosted domestic production capabilities.
The intravenous therapy and vein access devices market research report is one of a series of new reports that provides intravenous therapy and vein access devices market statistics, including intravenous therapy and vein access devices industry global market size, regional shares, competitors with a intravenous therapy and vein access devices market share, detailed intravenous therapy and vein access devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous therapy and vein access devices industry. This intravenous therapy and vein access devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intravenous therapy and vein access devices involve tools such as catheters and needles that allow fluids, medications, nutrients, and blood products to be administered directly into the bloodstream for precise and continuous medical care.
The key categories in the intravenous therapy and vein access devices market include intravenous (IV) therapy and vein access implantable ports, intravenous (IV) therapy and vein access intravenous catheters, hypodermic intravenous (IV) therapy and vein access needles, intravenous (IV) therapy and vein access infusion pumps, and others. Intravenous therapy and vein access implantable ports are compact devices implanted beneath the skin to provide long-term, reliable IV access, supporting repeated treatments while reducing discomfort from frequent needle insertions. The applications include volume expansion, medication delivery, blood products, nutritional solutions, and buffer solutions, and the end users include hospitals, clinics, and ambulatory surgical centers.
The intravenous therapy and vein access devices market consists of revenues earned by entities by providing services such as catheter insertion, intravenous administration, device maintenance, sterilization, training for healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The intravenous therapy and vein access devices market also includes sales of catheters, infusion pumps, and needleless connectors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intravenous therapy and vein access devices market size is expected to see strong growth in the next few years. It will grow to $48.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of implantable ports and advanced infusion pumps, rising adoption of needleless connectors and iv administration sets, expansion of ambulatory surgical centers, integration of smart monitoring and digital solutions, increasing investment in patient safety and regulatory compliance. Major trends in the forecast period include rising demand for peripheral and central venous access devices, increasing adoption of safety-engineered needles and catheters, growth in infusion pump technologies and patient-controlled analgesia systems, expansion of nutrition and medication administration applications, enhanced focus on sterility, accuracy, and regulatory compliance.
The increasing number of surgical procedures is increasingly supporting the expansion of the intravenous therapy and vein access devices market going forward. The rising demand for elective surgeries, including cosmetic procedures, plastic surgery, rhinoplasty, and other non-essential surgical interventions, has contributed significantly to the overall increase in surgical volumes. Intravenous therapy and vein access devices play a critical role in surgical settings by enabling the administration of anesthesia, medications, fluids, and nutrients, maintaining patient stability, and allowing rapid medical intervention when required. For example, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, the total number of surgical and non-surgical procedures increased by 3.4% in 2023 to reach 34.9 million. This increase was supported by a 5.5% rise in surgical procedures, with plastic surgeons performing over 15.8 million surgical procedures and 19.1 million non-surgical procedures, representing a 40% overall increase over the past four years. As a result, the growing volume of surgical procedures is contributing to the expansion of the intravenous therapy and vein access devices market.
Leading companies operating in the intravenous therapy and vein access devices market are developing short peripheral intravenous catheters to improve patient comfort, reduce insertion-related complications, and enhance the efficiency of fluid and medication delivery. Short peripheral intravenous catheters provide rapid and reliable venous access for administering fluids, medications, and nutrients while minimizing discomfort and lowering infection risk. For example, in October 2023, B. Braun, a Germany-based medical device company, launched the Introcan Safety 2 IV Catheter. This short peripheral catheter features passive needlestick prevention and a Multi-Access blood control septum, providing automatic needlestick protection and minimizing exposure to bloodborne pathogens each time the hub is accessed.
In June 2023, Merit Medical Systems, Inc., a US-based healthcare technology company, acquired the dialysis catheter product portfolio and the BioSentry Biopsy Tract Sealant System from AngioDynamics, Inc. for an undisclosed amount. Through this acquisition, Merit Medical aimed to strategically broaden its product portfolio in key markets, particularly dialysis and biopsy. AngioDynamics, Inc. is a US-based medical device company that supplies products for intravenous therapy, vein access, and other medical applications.
Major companies operating in the intravenous therapy and vein access devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., 3M Company, Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Terumo Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., Teleflex Incorporated, Smiths Medical, Nipro Corporation, Argon Medical Devices Inc., Angiplast Private Limited, Poly Medicure Limited, Iradimed Corporation.
North America was the largest region in the intravenous therapy and vein access devices market in 2025. The regions covered in the intravenous therapy and vein access devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravenous therapy and vein access devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intravenous therapy and vein access devices market by increasing the cost of imported catheters, needles, infusion pumps, and implantable ports. Segments such as advanced infusion pumps and implantable ports are most impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to elevated production costs and supply chain adjustments. On the positive side, tariffs have promoted local manufacturing, encouraged innovation in device design, and boosted domestic production capabilities.
The intravenous therapy and vein access devices market research report is one of a series of new reports that provides intravenous therapy and vein access devices market statistics, including intravenous therapy and vein access devices industry global market size, regional shares, competitors with a intravenous therapy and vein access devices market share, detailed intravenous therapy and vein access devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous therapy and vein access devices industry. This intravenous therapy and vein access devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intravenous therapy and vein access devices involve tools such as catheters and needles that allow fluids, medications, nutrients, and blood products to be administered directly into the bloodstream for precise and continuous medical care.
The key categories in the intravenous therapy and vein access devices market include intravenous (IV) therapy and vein access implantable ports, intravenous (IV) therapy and vein access intravenous catheters, hypodermic intravenous (IV) therapy and vein access needles, intravenous (IV) therapy and vein access infusion pumps, and others. Intravenous therapy and vein access implantable ports are compact devices implanted beneath the skin to provide long-term, reliable IV access, supporting repeated treatments while reducing discomfort from frequent needle insertions. The applications include volume expansion, medication delivery, blood products, nutritional solutions, and buffer solutions, and the end users include hospitals, clinics, and ambulatory surgical centers.
The intravenous therapy and vein access devices market consists of revenues earned by entities by providing services such as catheter insertion, intravenous administration, device maintenance, sterilization, training for healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The intravenous therapy and vein access devices market also includes sales of catheters, infusion pumps, and needleless connectors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intravenous Therapy and Vein Access Devices Market Characteristics
3. Intravenous Therapy and Vein Access Devices Market Supply Chain Analysis
4. Global Intravenous Therapy and Vein Access Devices Market Trends and Strategies
5. Intravenous Therapy and Vein Access Devices Market Analysis of End Use Industries
7. Global Intravenous Therapy and Vein Access Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intravenous Therapy and Vein Access Devices Total Addressable Market (TAM) Analysis for the Market
9. Intravenous Therapy and Vein Access Devices Market Segmentation
10. Intravenous Therapy and Vein Access Devices Market Regional and Country Analysis
11. Asia-Pacific Intravenous Therapy and Vein Access Devices Market
12. China Intravenous Therapy and Vein Access Devices Market
13. India Intravenous Therapy and Vein Access Devices Market
14. Japan Intravenous Therapy and Vein Access Devices Market
15. Australia Intravenous Therapy and Vein Access Devices Market
16. Indonesia Intravenous Therapy and Vein Access Devices Market
17. South Korea Intravenous Therapy and Vein Access Devices Market
18. Taiwan Intravenous Therapy and Vein Access Devices Market
19. South East Asia Intravenous Therapy and Vein Access Devices Market
20. Western Europe Intravenous Therapy and Vein Access Devices Market
21. UK Intravenous Therapy and Vein Access Devices Market
22. Germany Intravenous Therapy and Vein Access Devices Market
23. France Intravenous Therapy and Vein Access Devices Market
24. Italy Intravenous Therapy and Vein Access Devices Market
25. Spain Intravenous Therapy and Vein Access Devices Market
26. Eastern Europe Intravenous Therapy and Vein Access Devices Market
27. Russia Intravenous Therapy and Vein Access Devices Market
28. North America Intravenous Therapy and Vein Access Devices Market
29. USA Intravenous Therapy and Vein Access Devices Market
30. Canada Intravenous Therapy and Vein Access Devices Market
31. South America Intravenous Therapy and Vein Access Devices Market
32. Brazil Intravenous Therapy and Vein Access Devices Market
33. Middle East Intravenous Therapy and Vein Access Devices Market
34. Africa Intravenous Therapy and Vein Access Devices Market
36. Intravenous Therapy and Vein Access Devices Market Competitive Landscape and Company Profiles
37. Intravenous Therapy and Vein Access Devices Market Other Major and Innovative Companies
40. Intravenous Therapy and Vein Access Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intravenous Therapy And Vein Access Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intravenous therapy and vein access devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intravenous therapy and vein access devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous therapy and vein access devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Intravenous (IV) Therapy And Vein Access Implantable Ports; Intravenous (IV) Therapy And Vein Access Intravenous Catheters; Hypodermic Intravenous (IV) Therapy And Vein Access Needles; Intravenous (IV) Therapy And Vein Access Infusion Pumps; Other Types2) By Application: Volume Expanders; Medication Administration; Blood-Based Products; Nutrition And Buffer Solutions
3) By End Use: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Intravenous (IV) Therapy And Vein Access Implantable Ports: Single-Lumen Implantable Ports; Double-Lumen Implantable Ports; Triple-Lumen Implantable Ports2) By Intravenous (IV) Therapy And Vein Access Intravenous Catheters: Peripheral IV Catheters; Central Venous Catheters (CVC); Peripherally Inserted Central Catheters (PICC); Tunneled Catheters
3) By Hypodermic Intravenous (IV) Therapy And Vein Access Needles: Standard Hypodermic Needles; Butterfly Needles; Safety Hypodermic Needles
4) By Intravenous (IV) Therapy And Vein Access Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Patient-Controlled Analgesia (PCA) Pumps; Ambulatory Infusion Pumps
5) By Other Types: IV Administration Sets; IV Fluid Bags And Tubing; Needleless Connectors; IV Drip Chambers
Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson Services Inc.; 3M Company; Medtronic plc; Becton Dickinson and Company; Baxter International Inc.; B Braun Holding GmbH Co KG; Fresenius Kabi AG; Terumo Corporation; West Pharmaceutical Services Inc.; ICU Medical Inc.; Merit Medical Systems Inc.; Avanos Medical Inc.; Vygon SAS; AngioDynamics Inc.; Elcam Medical Inc.; Teleflex Incorporated; Smiths Medical; Nipro Corporation; Argon Medical Devices Inc.; Angiplast Private Limited; Poly Medicure Limited; Iradimed Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intravenous Therapy and Vein Access Devices market report include:- Cardinal Health Inc.
- Johnson & Johnson Services Inc.
- 3M Company
- Medtronic plc
- Becton Dickinson and Company
- Baxter International Inc.
- B Braun Holding GmbH Co KG
- Fresenius Kabi AG
- Terumo Corporation
- West Pharmaceutical Services Inc.
- ICU Medical Inc.
- Merit Medical Systems Inc.
- Avanos Medical Inc.
- Vygon SAS
- AngioDynamics Inc.
- Elcam Medical Inc.
- Teleflex Incorporated
- Smiths Medical
- Nipro Corporation
- Argon Medical Devices Inc.
- Angiplast Private Limited
- Poly Medicure Limited
- Iradimed Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 35.79 Billion |
| Forecasted Market Value ( USD | $ 48.1 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
